Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.356NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.356NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.462NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.462NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.462NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.147NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.147NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.147NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.6 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.6 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.6 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.5 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.5 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.5 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.4 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.4 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.4 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.420NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.420NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.39.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.39.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.39.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.233NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.233NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.233NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.320NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.320NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.320NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.635NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.635NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.635NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used